Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05136768 | Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)(LM-HNSCC) | unknown | Phase 2 | 50 | Jun-Lin Yi, MDUNKNOWN | 1 | Nov 29, 2021 | clinicaltrials |
| NCT05124938 | Assessment of CA 19-9 in Patients' With Thyroid Malignancies | unknown | — | 120 | Sohag UniversityOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT05117138 | Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors | unknown | Phase 1 / Phase 2 | 39 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Nov 11, 2021 | clinicaltrials |
| NCT05114707 | Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses | unknown | Phase 2 | 57 | Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2021 | clinicaltrials |
| NCT05112510 | Prognostic Prediction of NPC Based on MR Diffusion-weighted Imaging | unknown | — | 125 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT04367909 | A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma | unknown | Phase 2 | 68 | Xin-Hua XuOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03291002 | Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC | unknown | Phase 1 | 98 | CureVacINDUSTRY | 5 | Nov 4, 2021 | clinicaltrials |
| NCT04650633 | SHR-1701 in Patients With Recurrent/Metastatic Scchn | unknown | Phase 2 | 130 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Oct 29, 2021 | clinicaltrials |
| NCT05092217 | Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma | unknown | Phase 2 | 80 | Eye & ENT Hospital of Fudan UniversityOTHER | 0 | Oct 25, 2021 | clinicaltrials |
| NCT05087706 | Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer(MAPS)(MAPS) | unknown | — | 182 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT02041260 | A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting | unknown | Phase 2 | 43 | Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03146338 | Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)(OPTIMAG) | unknown | N/A | 106 | WepromOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03843515 | Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction(NeoNivo) | unknown | Phase 1 | 17 | Amsterdam UMC, location VUmcOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT04804852 | Assessment of the Prevalence of Sarcopenia by CT Scan in Patients Diagnosed With Head & Neck Cancer(SARVADS 1) | unknown | — | 50 | WepromOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT05065086 | Single Modality Trans Oral Robotic Surgery for Primary Oropharyngeal Cancer: Exploring the Impact of Surgical Margins on Local Disease Recurrence(STORM) | unknown | — | 500 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT05072327 | Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors. | unknown | N/A | 120 | Sun Yat-sen UniversityOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT03942380 | Cell-free Tumor DNA in Head and Neck Cancer Patients | unknown | N/A | 500 | Christian von BuchwaldOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT05040425 | Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis | unknown | Phase 2 | 200 | Chang Gung Memorial HospitalOTHER | 0 | Sep 10, 2021 | clinicaltrials |
| NCT03973450 | Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia(EpidemioPIT) | unknown | — | 400 | Neuromed IRCCSOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04265313 | Validity and Reliability of the Turkish Version of the Neck Dissection Impairment Index | unknown | — | 65 | Izmir Bakircay UniversityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT04265326 | Validity and Reliability of the Turkish Version of the Head and Neck Cancer Inventory | unknown | — | 165 | Izmir Bakircay UniversityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT04269148 | Validity and Reliability of the Turkish Version of the McMaster University Head and Neck Radiotherapy Questionnaire | unknown | — | 90 | Izmir Bakircay UniversityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT02512315 | A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma | unknown | Phase 3 | 192 | Sun Yat-sen UniversityOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT05024019 | Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery | unknown | Phase 2 | 95 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT04853680 | Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy. | unknown | N/A | 80 | Inha University HospitalOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT05020925 | SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Aug 25, 2021 | clinicaltrials |
| NCT03668730 | Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma | unknown | Phase 2 | 215 | Sun Yat-sen UniversityOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04992988 | Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial | unknown | Phase 2 | 40 | Cancer Hospital of Guangxi Medical UniversityOTHER | 1 | Aug 20, 2021 | clinicaltrials |
| NCT04539600 | Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer | unknown | Phase 2 | 23 | Sun Yat-sen UniversityOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT05013515 | Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas | unknown | N/A | 20 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Aug 19, 2021 | clinicaltrials |
| NCT05008796 | PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT | unknown | — | 50 | Chang Gung Memorial HospitalOTHER | 1 | Aug 18, 2021 | clinicaltrials |
| NCT05011500 | Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC)(MASSC) | unknown | N/A | 24 | Cancer Research AntwerpOTHER | 1 | Aug 18, 2021 | clinicaltrials |
| NCT05008237 | Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study | unknown | Phase 2 | 42 | Samsung Medical CenterOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT05009446 | Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM(SNMM) | unknown | Early Phase 1 | 28 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04999800 | Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1 | unknown | Phase 2 | 20 | Shi YuankaiUNKNOWN | 1 | Aug 11, 2021 | clinicaltrials |
| NCT03450967 | Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC | unknown | Phase 2 | 31 | Samsung Medical CenterOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04697446 | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC | unknown | — | 279 | Blueprint Medicines CorporationINDUSTRY | 3 | Aug 10, 2021 | clinicaltrials |
| NCT04658706 | The SEHNeCa Supervised Exercise Project(SEHNeCa) | unknown | N/A | 120 | Basque Health ServiceOTHER_GOV | 1 | Jul 23, 2021 | clinicaltrials |
| NCT04242459 | Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers(INSIGHT-2) | unknown | Phase 1 / Phase 2 | 73 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 22, 2021 | clinicaltrials |
| NCT04955886 | Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 14 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 9, 2021 | clinicaltrials |
| NCT04951557 | Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas | unknown | — | 5,000 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT04952116 | Aesthetic and Functional Outcomes of Eyelid Reconstruction After Excision of Periocular Tumors | unknown | N/A | 20 | Sohag UniversityOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT04938401 | Construction and Application of a Risk Prediction Model Forepistaxis After Pituitary Tumor Resection | unknown | — | 1 | Wang Ying supervisor nurseOTHER | 0 | Jun 24, 2021 | clinicaltrials |
| NCT03904225 | Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis | unknown | Phase 2 | 220 | Zhejiang Cancer HospitalOTHER | 1 | Jun 23, 2021 | clinicaltrials |
| NCT04933357 | Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy (MART) | unknown | Phase 2 / Phase 3 | 75 | National Cancer Institute, EgyptOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT04916262 | Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer | unknown | — | 160 | Qianfoshan HospitalOTHER | 0 | Jun 16, 2021 | clinicaltrials |
| NCT04905030 | Education, Immigration and HPV Vaccination: an Informational Randomized Trial | unknown | N/A | 2,500 | Karolinska InstitutetOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT04922450 | Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 53 | Hunan Cancer HospitalOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT04919460 | Research on Optimization and Evaluation of Oral Cancer Screening Methods | unknown | Early Phase 1 | 10,000 | Hunan Cancer HospitalOTHER | 0 | Jun 9, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Nov 29, 2021source: clinicaltrials